 |
 |
 |
 |
 |
 |
 |
 |
E-Mail
ShareAdverse Events of HIV/HAART
General | Anemia | Bone Problems | Gastrointestinal Problems | Heart Disease and HIV | Fatigue | Facial Wasting/Lipoatrophy | Immune Reconstitution Syndrome | Insomnia | Hypersensitivity Reaction | Lipodystrophy and Other Metabolic Complications | Medication-Related Liver Problems| Neuropathy | Pancreatitis | Renal Complications | Lactic Acidosis | Sexual Dysfunction | Skin Complications | Women-Specific General HIV Complications | Other
See also: Structured HIV Treatment Interruptions
General
- Looking Ahead: NIAID's Future HIV/AIDS Therapeutics Priorities (June 30, 2010)
From AIDS.gov - FDA Probes Risks of HIV, Prostate, Other Drugs (May 4, 2010)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - CROI 2010 Wrap-Up: Complications of HIV and Its Treatment (March 30, 2010)
A discussion with Pablo Tebas, M.D.
In The 17th Conference on Retroviruses and Opportunistic Infections, from The Body PRO - Side Effect and CD4 Differences in Four ACTG 5202 Arms at 96 Weeks (February 18, 2010)
From National AIDS Treatment Advocacy Project - Antiretroviral Therapy-Associated Adverse Effects and Management Recommendations (PDF) (December 1, 2009)
An excerpt from the official U.S. HIV treatment guidelines for adults and adolescents. For the full guidelines, click here (PDF).
From AIDSinfo - Reporting Adverse Events to the U.S. Food and Drug Administration (December 20, 2007)
From U.S. Food and Drug Administration - Adverse Effects of Antiretroviral Drugs (November 2007)
A clinical overview from an online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite - Adverse Events of Antiretroviral Drugs (November 2007)
From AIDS Education & Training Centers National Resource Center - Adverse Events Due to Non-Antiretroviral Medications During Treatment of HIV-Related Infections and Complications (May 2006)
A clinical overview from an online textbook of HIV disease from the University of California San Francisco and San Francisco General Hospital.
From HIV InSite - Severe Events Unrelated to AIDS or Antiretrovirals Were Most Common in Early HAART Patients (December 16, 2005)
[Archived Article]
In The 45th Interscience Conference on Antimicrobial Agents and Chemotherapy - Are People Getting the Help They Need for Side Effects? (Summer 2005)
[Archived Article]
Results from a 381-person survey of New Yorkers taking HIV treatment, with a focus on the impact of side effects.
To read PDF, click here.
In ACRIA Update, from AIDS Community Research Initiative of America - Five Ways to Tackle Toxicity (or the Ant, the Spider, and the Bee): 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV (January 2005)
[Archived Article]
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Not Undetectable, but Still Content (December 2004)
[Archived Article]
Some HIV-positive people have decided that the benefits of having an undetectable viral load don't outweigh the health risks of potent HIV medications.
In POZ - HAART Side Effects More Likely Among Those With High Viral Loads (July 6, 2004)
[Archived Article]
Up to 13% of HIV-positive people experience a severe side effect within a year after beginning HAART; side effects are likelier in those with baseline viral load over 100,000.
In aidsmap.com - Can Uridine Supplements Protect People With HIV/AIDS From Drug Toxicity? (April 29, 2004)
[Archived Article]
From Canadian AIDS Treatment Information Exchange - Surviving AIDS, but Still at Risk (March 7, 2004)
[Archived Article]
As most people with HIV know, antiretrovirals may prolong life, but they also carry their own dangers.
In Milwaukee Journal Sentinel - Why People With HIV Still Die -- And Why They Don't Have To (March 2004)
To read PDF, click here.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Testimony on Accelerated Approval: September 1994 (November 2003)
[Archived Article]
Carlton Hogan's warnings about the need to study long-term drug toxicities are as poignant today as they were nine years ago.
In GMHC Treatment Issues, from Gay Men's Health Crisis - Drug Side Effects Chart (November 2003)
[Archived Article]
To read PDF, click here.
From Project Inform - Protease Inhibitors and Severe Adverse Events (July 14, 2003)
[Archived Article]
In The 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment, from The Body PRO - Women and HIV: The Impact of Sex/Gender on Antiretroviral Therapy and Its Complications (Summer 2003)
[Archived Article]
Kathleen Squires, M.D., speaks at the 2nd International AIDS Society Conference on HIV Pathogenesis and Treatment.
To read PDF, click here.
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation - HIV 101: Chart of Common Toxicities Among Antiretrovirals (June 2003)
[Archived Article]
To read PDF, click here.
In HEPP Report, from Brown Medical School - Long-Term Toxicities Associated With HIV and Antiretroviral Therapy (June 2003)
[Archived Article]
Brief overviews of many common HAART side effects.
To read PDF, click here.
In HEPP Report, from Brown Medical School - Intentional Nonadherence to HAART Common Due to Side Effects, Study Finds (October 31, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Study Examines Mortality Factors in HIV Patients on Protease Inhibitors (October 10, 2002)
[Archived Article]
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention - Sex Hormones and HAART (April 11, 2002)
[Archived Article]
From Canadian AIDS Treatment Information Exchange - Emerging Complications of HIV Therapy (December 18, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Pancreatitis: An Emerging Complication of HCV Treatment in HIV Co-Infected Patients Treated With Didanosine/Stavudine Containing Regimens (December 17, 2001)
[Archived Article]
In 41st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC 2001), from The Body PRO - Study Finds Women More Likely to Get Rash With Nevirapine Than Men (August 16, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange - Does Efavirenz (Sustiva) Cause Breast Enlargement? (August 1, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange - Tattoos Flare Up From HAART (May 28, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange - High Blood Pressure With Indinavir (May 25, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange - A New Side Effect From Kaletra? (May 25, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange - Hearing Loss May Be Linked to Use of Nukes (May 16, 2001)
[Archived Article]
From Canadian AIDS Treatment Information Exchange - Vitamin Cocktail Helps People Recover From Nuke Side Effects (December 20, 2000)
[Archived Article]
From Canadian AIDS Treatment Information Exchange - Adverse Reactions to HIV Medications (2006)
A chapter from Clinical Manual for Management of the HIV-Infected Adult.
From AIDS Education & Training Centers National Resource Center
Other
- Five Times Higher Risk of Intracranial Hemorrhage With HIV (July 22, 2010)
From National AIDS Treatment Advocacy Project - New, Deadly, but Rare Encephalitis Described in 14 French HIV Patients (July 21, 2010)
From National AIDS Treatment Advocacy Project - Light Sensitivity More Common Among People on HIV Treatment, Study Finds (April 26, 2006)
In Kaiser Daily HIV/AIDS Report, from Henry J. Kaiser Family Foundation - Long-Term Tenofovir Use May Be Associated With Mild Nephrotoxicity (May/June 2005)
From The Body PRO - Breast Enlargement in Men May Be Linked to d4T, ddI, Efavirenz (October 2004)
[Archived Article]
Quick recap of studies in the journal AIDS and The Breast Journal.
In HIV Treatment ALERTS!, from The Center for AIDS - Reasons for Early Abacavir Discontinuation in HIV-Infected Patients (November 2003)
[Archived Article]
Abstract of a study in the Annals of Pharmacotherapy.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Toxicity Mechanisms of ART (September 2003)
[Archived Article]
2nd International AIDS Society Conference on HIV Pathogenesis and Treatment.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Hepatitis, Mental Illness, and Substance Abuse: Managing the Triple-Diagnosed HIV Patient (July 2003)
[Archived Article]
Highlights for healthcare professionals from the IAPAC Sessions 2003.
In IAPAC Monthly, from International Association of Physicians in AIDS Care - Emerging Toxicity of HIV Therapy? Skeletal Muscle Damage (May 6, 2003)
[Archived Article]
To read PDF, click here.
In STEP Ezine, from Seattle Treatment Education Project - Three French Cases of Tenofovir Kidney Toxicity Reported Amongst HIV-Positive Patients (April 8, 2003)
[Archived Article]
From aidsmap.com - HIV-Positive Man Dies of Kidney Failure and Lactic Acidosis Due to Tenofovir/ddI Interaction (April 8, 2003)
[Archived Article]
From aidsmap.com - Drug Interaction: Ritonavir and Fluticasone (November 2001)
[Archived Article]
Possible link found to Cushing's Syndrome.
In HIV Treatment ALERTS!, from The Center for AIDS - Ingrown Toenails Still a Possible Side Effect (November 2001)
[Archived Article]
Indinavir-ritonavir interaction is possible culprit.
In HIV Treatment ALERTS!, from The Center for AIDS - Mitochondrial and Mitochondrial-Like Symptoms in Children Born to HIV-Infected Mothers. Exhaustive Evaluation in a Large Prospective Cohort (February 7, 2001)
[Archived Article]
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
The Body PRO is a service of Body Health Resources Corporation, 250 West 57th Street, New York, NY 10107. The Body PRO and its logos are trademarks of Body Health Resources Corporation, which owns the copyright of The Body PRO's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body PRO is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body PRO should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.